PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jmedgeneJournal of Medical GeneticsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
J Med Genet. 1999 February; 36(2): 119–124.
PMCID: PMC1734295

Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis

Abstract

21-hydroxylase deficiency is a recessively inherited disorder of steroidogenesis, resulting from mutations in the CYP21 gene. This 3.5 kb gene and a highly related CYP21P pseudogene reside on tandemly duplicated 30 kb segments of DNA in the class III HLA region, and the great majority of pathogenic mutations result from sequence exchanges involving the duplicated units. We now describe a comprehensive survey of CYP21 mutations in the British population, encompassing a screen for 17 different mutations in a total of 284 disease chromosomes. The most common mutations were as follows: large scale deletions/conversions (45% of the affected chromosomes), the intron 2 splice mutation (30.3%), R357W (9.8%), and I172N (7.0%). Mutations were detected in over 92% of the chromosomes examined, suggesting that accurate DNA based diagnosis is possible in most cases using the described strategy. In order to extend highly accurate prenatal diagnosis to all families where samples are available from a previously affected child, we have developed a linkage analysis approach using novel, highly informative microsatellite markers from the class III HLA region.


Keywords: 21-hydroxylase deficiency; CYP21; mutation screening

Full Text

The Full Text of this article is available as a PDF (154K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Carroll MC, Campbell RD, Porter RR. Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci U S A. 1985 Jan;82(2):521–525. [PubMed]
  • White PC, Grossberger D, Onufer BJ, Chaplin DD, New MI, Dupont B, Strominger JL. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1089–1093. [PubMed]
  • Bristow J, Tee MK, Gitelman SE, Mellon SH, Miller WL. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol. 1993 Jul;122(1):265–278. [PMC free article] [PubMed]
  • Bristow J, Tee MK, Gitelman SE, Mellon SH, Miller WL. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol. 1993 Jul;122(1):265–278. [PMC free article] [PubMed]
  • Speek M, Barry F, Miller WL. Alternate promoters and alternate splicing of human tenascin-X, a gene with 5' and 3' ends buried in other genes. Hum Mol Genet. 1996 Nov;5(11):1749–1758. [PubMed]
  • Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci U S A. 1986 May;83(9):2841–2845. [PubMed]
  • White PC, New MI, Dupont B. Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5111–5115. [PubMed]
  • Strachan T. Molecular pathology of 21-hydroxylase deficiency. J Inherit Metab Dis. 1994;17(4):430–441. [PubMed]
  • Newfield RS, New MI. 21-hydroxylase deficiency. Ann N Y Acad Sci. 1997 Jun 17;816:219–229. [PubMed]
  • Collier S, Sinnott PJ, Dyer PA, Price DA, Harris R, Strachan T. Pulsed field gel electrophoresis identifies a high degree of variability in the number of tandem 21-hydroxylase and complement C4 gene repeats in 21-hydroxylase deficiency haplotypes. EMBO J. 1989 May;8(5):1393–1402. [PubMed]
  • Sinnott P, Collier S, Costigan C, Dyer PA, Harris R, Strachan T. Genesis by meiotic unequal crossover of a de novo deletion that contributes to steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2107–2111. [PubMed]
  • Tusié-Luna MT, White PC. Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10796–10800. [PubMed]
  • Collier S, Tassabehji M, Sinnott P, Strachan T. A de novo pathological point mutation at the 21-hydroxylase locus: implications for gene conversion in the human genome. Nat Genet. 1993 Mar;3(3):260–265. [PubMed]
  • Higashi Y, Tanae A, Inoue H, Fujii-Kuriyama Y. Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: implications for steroid 21-hydroxylase deficiency. Am J Hum Genet. 1988 Jan;42(1):17–25. [PubMed]
  • Wedell A, Chun X, Luthman H. A steroid 21-hydroxylase allele concomitantly carrying four disease-causing mutations is not uncommon in the swedish population. Hum Genet. 1994 Feb;93(2):204–206. [PubMed]
  • Higashi Y, Hiromasa T, Tanae A, Miki T, Nakura J, Kondo T, Ohura T, Ogawa E, Nakayama K, Fujii-Kuriyama Y. Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem. 1991 Apr;109(4):638–644. [PubMed]
  • Sinnott PJ, Costigan C, Dyer PA, Harris R, Strachan T. Extended MHC haplotypes and CYP21/C4 gene organisation in Irish 21-hydroxylase deficiency families. Hum Genet. 1991 Jul;87(3):361–366. [PubMed]
  • Sinnott PJ, Livieri C, Sampietro M, Marconi M, Harris R, Severi F, Strachan T. CYP21/C4 gene organisation in Italian 21-hydroxylase deficiency families. Hum Genet. 1992 Mar;88(5):545–551. [PubMed]
  • Wedell A, Thilén A, Ritzén EM, Stengler B, Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab. 1994 May;78(5):1145–1152. [PubMed]
  • Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab. 1995 Aug;80(8):2322–2329. [PubMed]
  • Barbat B, Bogyo A, Raux-Demay MC, Kuttenn F, Boué J, Simon-Bouy B, Serre JL, Mornet E. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency. Hum Mutat. 1995;5(2):126–130. [PubMed]
  • Ezquieta B, Oliver A, Gracia R, Gancedo PG. Analysis of steroid 21-hydroxylase gene mutations in the Spanish population. Hum Genet. 1995 Aug;96(2):198–204. [PubMed]
  • Tusié-Luna MT, Ramírez-Jiménez S, Ordóez-Sánchez ML, Cabello-Villegas J, Altamirano-Bustamante N, Calzada-León R, Robles-Valdés C, Mendoza-Morfín F, Méndez JP, Terán-García M. Low frequency of deletion alleles in patients with steroid 21-hydroxylase deficiency in a Mexican population. Hum Genet. 1996 Sep;98(3):376–379. [PubMed]
  • Carrera P, Bordone L, Azzani T, Brunelli V, Garancini MP, Chiumello G, Ferrari M. Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency. Hum Genet. 1996 Dec;98(6):662–665. [PubMed]
  • Levo A, Partanen J. Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles. Hum Genet. 1997 Apr;99(4):488–497. [PubMed]
  • Lajic S, Wedell A. An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia. Hum Genet. 1996 Aug;98(2):182–184. [PubMed]
  • Strachan T, Sinnott PJ, Smeaton I, Dyer PA, Harris R. Prenatal diagnosis of congenital adrenal hyperplasia. Lancet. 1987 Nov 28;2(8570):1272–1273. [PubMed]
  • Sinnott PJ, Dyer PA, Price DA, Harris R, Strachan T. 21-hydroxylase deficiency families with HLA identical affected and unaffected sibs. J Med Genet. 1989 Jan;26(1):10–17. [PMC free article] [PubMed]
  • Wedell A, Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Hum Mol Genet. 1993 May;2(5):499–504. [PubMed]
  • Day DJ, Speiser PW, Schulze E, Bettendorf M, Fitness J, Barany F, White PC. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet. 1996 Dec;5(12):2039–2048. [PubMed]
  • Hsieh SL, March RE, Khanna A, Cross SJ, Campbell RD. Mapping of 10 novel microsatellites in the MHC class III region: application to the study of autoimmune disease. J Rheumatol. 1997 Jan;24(1):220–222. [PubMed]
  • Wedell A, Ritzén EM, Haglund-Stengler B, Luthman H. Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7232–7236. [PubMed]
  • Wilson RC, Wei JQ, Cheng KC, Mercado AB, New MI. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J Clin Endocrinol Metab. 1995 May;80(5):1635–1640. [PubMed]
  • Lee HH, Chao HT, Ng HT, Choo KB. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J Med Genet. 1996 May;33(5):371–375. [PMC free article] [PubMed]
  • Oriola J, Plensa I, Machuca I, Pavía C, Rivera-Fillat F. Rapid screening method for detecting mutations in the 21-hydroxylase gene. Clin Chem. 1997 Apr;43(4):557–561. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Group